World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01572194
Date of registration: 28/03/2012
Prospective Registration: Yes
Primary sponsor: Nantes University Hospital
Public title: Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC) MUCO-IRC
Scientific title: Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation.
Date of first enrolment: April 2012
Target sample size: 45
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT01572194
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Bearer of lung transplantation (single or double lung, with or without associated
cardiac transplantation)

- Suffering from cystic fibrosis

- Aged 18 and over

- With at least 6 months of transplantation

- Having a glomerular filtration rate measured by technical radionuclide > 30 ml / min

- Having given written consent to the study Patients meeting these criteria will enter
in the "organic" in the study (determination of PIIINP urinary)

Exclusion Criteria:

- Lung transplantation for a condition other than cystic fibrosis

- Patient refused follow-up

- Patients with advanced liver disease (conditions that interfere with the assay of
PIIINP)

- Minor

- Pregnant women,

- Major Trust, benefiting from a regime of legal protection (guardianship, trusteeship,
safeguarding justice.

- Patient unable to grant informed consent.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Renal Failure
Cystic Fibrosis
Lung Transplantation
Intervention(s)
Biological: Urinary levels of PIIINP as a marker of changes in renal function
Primary Outcome(s)
The correlation between the rate of urinary PIIINP inclusion in the study and the variation of the isotopic measurement of GFR over the 2 year study [Time Frame: 3 years]
Secondary Outcome(s)
Description of histological lesions present after transplantation from renal biopsies performed in all patients with chronic renal failure defined by a GFR between 30 and 60 ml / min and / or proteinuria> 1 g / d. [Time Frame: 3 years]
Correlation between the rate of urinary PIIINP and glomerular filtration rate measured by scintigraphy Chrome-EDTA at study entry and after 2 years of follow-up [Time Frame: 3 years]
Correlation between the rate of PIIINP urinary and the rate of first and second intensity of renal fibrosis histologically assessed renal biopsies that have been conducted in patients. [Time Frame: 3 years]
Secondary ID(s)
RC11_0215
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history